Your browser doesn't support javascript.
loading
Rabies Virus Neutralizing Activity, Safety, and Immunogenicity of Recombinant Human Rabies Antibody Compared with Human Rabies Immunoglobulin in Healthy Adults.
Zhang, Jun Nan; Meng, Ya Juan; Bai, Yun Hua; Li, Yu Feng; Yang, Li Qing; Shi, Nian Min; Han, Hui Xia; Gao, Jian; Zhu, Li Juan; Li, Shu Ping; Zhang, Jing; Zhao, Qin Hua; Wang, Xiu Qin; Wei, Jing Shuang; Ren, Le Min; Cao, Chen Hua; Chen, Chen; Zhao, Wei; Li, Li.
Afiliación
  • Zhang JN; Center for Disease Control and Prevention of Chaoyang District, Beijing 100021, China.
  • Meng YJ; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Bai YH; Center for Disease Control and Prevention of Chaoyang District, Beijing 100021, China.
  • Li YF; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Yang LQ; Center for Disease Control and Prevention of Chaoyang District, Beijing 100021, China.
  • Shi NM; Beijing Institute of Biological Products, Beijing 100021, China.
  • Han HX; Xiaohongmen Community Healthcare Center, Beijing 100023, China.
  • Gao J; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Zhu LJ; Xiaohongmen Community Healthcare Center, Beijing 100023, China.
  • Li SP; Center for Disease Control and Prevention of Chaoyang District, Beijing 100021, China.
  • Zhang J; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Zhao QH; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Wang XQ; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Wei JS; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Ren LM; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Cao CH; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Chen C; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Zhao W; NCPC New Drug Research and Development Co., Ltd., State Key Laboratory of Antibody Research & Development, Shijiazhuang 050015, Hebei, China.
  • Li L; Center for Disease Control and Prevention of Chaoyang District, Beijing 100021, China.
Biomed Environ Sci ; 35(9): 782-791, 2022 Sep 20.
Article en En | MEDLINE | ID: mdl-36189993
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabia / Virus de la Rabia / Vacunas Antirrábicas Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Biomed Environ Sci Asunto de la revista: SAUDE AMBIENTAL Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabia / Virus de la Rabia / Vacunas Antirrábicas Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Biomed Environ Sci Asunto de la revista: SAUDE AMBIENTAL Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China